Aspirin, interleukin-3 and the antiphospholipid syndrome.
Fishman
P
P
Immunology Research Unit, Golda Medical Center, Hasharon Hospital, Petah Tikva, Israel.
Shoenfeld
Y
Y
D000818:Animals; D016736:Antiphospholipid Syndrome / Q000188:drug therapy* / Q000378:metabolism; D016718:Arachidonic Acid / Q000378:metabolism / Q000494:pharmacology; D001241:Aspirin / Q000627:therapeutic use*; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007377:Interleukin-3 / Q000096:biosynthesis*; D051379:Mice; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications / Q000188:drug therapy / Q000378:metabolism
D016861:Cyclooxygenase Inhibitors; D007377:Interleukin-3; D010975:Platelet Aggregation Inhibitors; D016718:Arachidonic Acid; D001241:Aspirin